Depends on production costs, can make the inactivated virus vaccine easily. mRNA vaccines were about 95% effective against symptomatic disease, but only agains

Depends on production costs, can make the inactivated virus vaccine easily. mRNA vaccines were about 95% effective against symptomatic disease, but only against the targeted strain.